The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study

Affiliations

• ¹ Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
• ² Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
• ³ National and Kapodistrian University of Athens, 'Aghia Sophia' Children's Hospital, Athens, Greece.
• ⁴ St Paul's Hospital, Vancouver, British Columbia, Canada.
• ⁵ Altasciences, Montreal, Quebec, Canada.
• ⁶ Chiesi Canada Corporation, Toronto, Ontario, Canada.
• ⁷ Apotex Inc, Toronto, Ontario, Canada.
• ⁸ New York Presbyterian Hospital/Weill Cornell Medical College, New York, New York, USA.
• ⁹ University of Turin, Turin, Italy.